🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Business news, market intelligence, and global industry analysis.
The Latest

Bharat Parenterals gets license and authorization for Favipiravir oral suspension for Covid treatment

bySrinath
May 22, 2021
Total
0
Shares
0
0
0

Bharat Parenterals said that it has secured the license and authorization from Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organisation (CDSCO) for the manufacturing and marketing of Favipiravir oral suspension l00mg/ml for the treatment of Covid-19.

The Gujarat-based pharma company said that the product patent for its Favipiravir oral suspension l00mg/ml has already been filed under fast track approval.

Bharat Parenterals gets license and authorization for Favipiravir oral suspension for Covid treatment
Bharat Parenterals gets license and authorization for Favipiravir oral suspension for Covid treatment. Image courtesy of visuals3Dde from Pixabay.

Bharat Parenterals said that it is the first in the Indian market to get the license and authorization for manufacturing and commercializing the Covid-19 treatment.

Earlier this month, Vivimed Labs launched Favulous, a generic version of Covid-19 drug Favipiravir Tablet 200 mg and 400 mg in India.

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

See also  How elraglusib’s long-term Phase 2 survival data positions Actuate Therapeutics in a difficult pancreatic cancer market
Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Boehringer Ingelheim, MD Anderson to advance new cancer treatments

German pharmaceutical giant Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center are joining forces to form a new virtual research and development center (R&D center) to rapidly advance new cancer treatments, covering various forms of the disease including lung and gastrointestinal cancers. The new virtual R&D center is expected to facilitate the […]

The post Boehringer Ingelheim, MD Anderson to advance new cancer treatments appeared first on PharmaNewsDaily.com.

bypharmanewsdaily